LAXATIVE PLUS SOFTENER 8.6 MG — DIN 02322420
SENNOSIDES : 8.6 MG DOCUSATE SODIUM : 50 MG · CELLCHEM PHARMACEUTICALS INC. · TABLET · wholesale supply in Canada
Health Canada status: APPROVED
What is LAXATIVE PLUS SOFTENER?
LAXATIVE PLUS SOFTENER 8.6 MG contains SENNOSIDES : 8.6 MG DOCUSATE SODIUM : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02322420, held by CELLCHEM PHARMACEUTICALS INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 22-Jan-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Senna Glycosides, Combinations cost around the world?
Senna Glycosides, Combinations is listed on 3 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Iceland publishes a max wholesale; United Kingdom publishes a hospital; United States publishes a acquisition. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 3 | 14 | USD███.██ |
| Iceland | max wholesale | 3 | 4 | ISK███.██ |
| United Kingdom | hospital | 3 | 3 | GBP███.██ |
21 pack listings across 9 brand entries and 3 price bases, refreshed 03 Sep 2026. Ranges span every Senna Glycosides, Combinations pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Senna Glycosides, Combinations in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
17 holders have a Canadian DIN containing Senna Glycosides, Combinations, across 18 DINs, of which 5 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| INOVA PHARMACEUTICALS (SINGAPORE) PTE. LTD. | 1 | 1 | SENOKOT S | Sourceable in Canada |
| PHARMASCIENCE INC | 1 | 1 | COLACE PLUS STIMULANT LAXATIVE | Sourceable in Canada |
| SIGMA LIFE SCIENCES INC. | 1 | 1 | SENNA S. TABLETS | Sourceable in Canada |
| TIME-CAP LABORATORIES, INC | 1 | 1 | TIMELY SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG TABLETS | Sourceable in Canada |
| VITA HEALTH PRODUCTS INC | 1 | 1 | SENNA LAXATIVE AND DOCUSATE SODIUM TABLETS | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 2 | 0 | DOCUSEN, JAMP-SENNA S | No marketed DIN |
| CELLCHEM PHARMACEUTICALS INC. | 1 | 0 | LAXATIVE PLUS SOFTENER | No marketed DIN |
| PHARMALAB INC. | 1 | 0 | LAXATIF DE SENE ET DOCUSATE DE SODIUM | No marketed DIN |
| PURITY LIFE HEALTH PRODUCTS A DIVISION OF SUNOPTA INC. | 1 | 0 | LAXATIVE TEA | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 1 | 0 | SANDOZ SENNA S | No marketed DIN |
| THE SHANDEX SALES GROUP LIMITED | 1 | 0 | SENNA DOCUSATE | No marketed DIN |
| WESTWARD DISTRIBUTORS | 1 | 0 | CENNLACS | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 8.6 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Senna Glycosides, Combinations |
|---|---|
| ATC code | A06AB56 |
| AHFS class | 28:16.08.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02322420 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2322420 |
| Brand name | LAXATIVE PLUS SOFTENER |
| Generic / active ingredient | SENNOSIDES : 8.6 MG DOCUSATE SODIUM : 50 MG |
| Market authorization holder | CELLCHEM PHARMACEUTICALS INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AB56 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A06AB |
| Current status | APPROVED |
| Status date | 22-Jan-2020 |
| Original market date | 2009-09-30 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
5 of 18 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| COLACE PLUS STIMULANT LAXATIVE | 8.6 MG | TABLET | PHARMASCIENCE INC | MARKETED | 02516209 |
| SENNA LAXATIVE AND DOCUSATE SODIUM TABLETS | 50 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02247134 |
| SENNA S. TABLETS | 8.6 MG | TABLET | SIGMA LIFE SCIENCES INC. | MARKETED | 02246951 |
| SENOKOT S | 50 MG | TABLET | INOVA PHARMACEUTICALS (SINGAPORE) PTE. LTD. | MARKETED | 00026123 |
| TIMELY SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG TABLETS | 50 MG | TABLET | TIME-CAP LABORATORIES, INC | MARKETED | 02553007 |
| CENNLACS | 182 MG | POWDER | WESTWARD DISTRIBUTORS | CANCELLED POST MARKET | 00552682 |
| DOCUSEN | 100 MG | TABLET | JAMP PHARMA CORPORATION | APPROVED | 02371650 |
| EX-LAX GENTLE STRENGTH | 65 MG | TABLET | NOVARTIS CONSUMER HEALTH CANADA INC. | CANCELLED POST MARKET | 02241666 |
| JAMP-SENNA S | 50 MG | TABLET | JAMP PHARMA CORPORATION | DORMANT | 02291215 |
| LAXATIF DE SENE ET DOCUSATE DE SODIUM | 8.6 MG | TABLET | PHARMALAB INC. | CANCELLED PRE MARKET | 02270293 |
2 · Same class — other molecules in ATC A06AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Bisacodyl | AG-BISACODYL EC · ALOPHEN TABLETS · AMB-BISACODYL · APO-BISACODYL · +46 more | 59 | 16 | Yes |
| Senna Glycosides, Combinations | CENNLACS · COLACE PLUS STIMULANT LAXATIVE · DOCUSEN · EX-LAX GENTLE STRENGTH · +14 more | 18 | 5 | Yes |
| Sodium Picosulfate, Combinations | CITRACLEEN · ORAL PURGATIVE · PICO-SALAX · PICODAN · +2 more | 6 | 2 | Yes |
| Bisacodyl, Combinations | BI-PEGLYTE · FRUITATIVES ECT · GENTLAX S · JAMPLYTE + BISACODYL | 4 | 2 | Yes |
| Contact Laxatives In Combination | AID-LAX TAB · ALSILINE · BEKUNIS DRAGEES · BICHOLATE LILAS · +54 more | 60 | 0 | Not in Canada |
| Cascara | AROMATIC CASCARA SAGRADA COMPOUND · BIOFANT - 41MG/5ML · CASCARA AROMATIC · CASCARA AROMATIC LIQ 250MG · +15 more | 21 | 0 | Not in Canada |
| Cascara, Combinations | ACIDOBYL & CASCARA · ALSILAX · BYLIUM LIQ · CHOLETOL · +15 more | 19 | 0 | Not in Canada |
| Senna Glycosides | AGAROL EXTRA STRENGTH CHEWABLE LAXATIVE TABLETS · AGAROL WITH SENNOSIDES · CASTORIA LIQ 0.7MG/ML · FLORA HERBTEA SENNA LEAVES · +14 more | 19 | 0 | Not in Canada |
| Castor Oil | CASTOR OIL · CASTOR OIL CERTIFIED · CASTOR OIL LIQ · CASTOR OIL LIQ 100% · +6 more | 12 | 0 | Not in Canada |
| Phenolphthalein, Combinations | CALCIUM DOCUPHEN CAP · CORRECTOL LAXATIVE TAB · DOXIDAN CAPSULES · EX-LAX LIGHT FORMULA LAX W STOOL SOFTEN TAB · +2 more | 9 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A06AA | Docusate Sodium · Docusate Sodium, Combinations · Liquid Paraffin · Liquid Paraffin, Combinations | 144 | 22 |
| A06AD | Lactulose · Macrogol · Macrogol, Combinations · Magnesium Oxide · Magnesium Sulphate · +5 more | 86 | 21 |
| A06AX | Glycerol · Linaclotide · Lubiprostone · Other Laxatives · Plecanatide · +2 more | 30 | 14 |
| A06AH | Methylnaltrexone Bromide · Naloxegol | 5 | 3 |
| A06AG | Bisacodyl · Combinations · Docusate Sodium, Incl Combinations · Sodium Phosphate | 7 | 1 |
| A06AC | Ispaghula (Psylla Seeds) · Ispaghula, Combinations · Linseed · Methylcellulose · Polycarbophil Calcium · +2 more | 79 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is LAXATIVE PLUS SOFTENER called?
The same molecule, Senna Glycosides, Combinations, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Senokot | Latin | Iceland |
| Senease | Latin | Iceland |
| Senna | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.